You are here

Our Advances in CF

Understanding CF   |   Voices of CF   |   Advances in CF   |   Vertex CF Community & Grant Programs


 

Our cystic fibrosis program began as a small research project in 1998. Today, Vertex has the most CF compounds in clinical development in the industry, and is focused on developing medicines for all people with CF. Learn about our leading role in creating medicines that address the underlying cause of CF.

Learn more about Vertex's CF program >